DE60328010D1 - Heterocyclische verbindungen - Google Patents
Heterocyclische verbindungenInfo
- Publication number
- DE60328010D1 DE60328010D1 DE60328010T DE60328010T DE60328010D1 DE 60328010 D1 DE60328010 D1 DE 60328010D1 DE 60328010 T DE60328010 T DE 60328010T DE 60328010 T DE60328010 T DE 60328010T DE 60328010 D1 DE60328010 D1 DE 60328010D1
- Authority
- DE
- Germany
- Prior art keywords
- heterocyclic compounds
- compounds
- compositions
- therapy
- pharmaceutically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201185A SE0201185D0 (sv) | 2002-04-18 | 2002-04-18 | Heterocyclic compounds |
SE0203606A SE0203606D0 (sv) | 2002-12-04 | 2002-12-04 | Heterocyclic compounds |
PCT/SE2003/000615 WO2003087104A1 (en) | 2002-04-18 | 2003-04-15 | Heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60328010D1 true DE60328010D1 (de) | 2009-07-30 |
Family
ID=29253787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60328010T Expired - Lifetime DE60328010D1 (de) | 2002-04-18 | 2003-04-15 | Heterocyclische verbindungen |
Country Status (17)
Country | Link |
---|---|
US (1) | US7417050B2 (de) |
EP (1) | EP1499616B1 (de) |
JP (1) | JP4523775B2 (de) |
KR (1) | KR20040099446A (de) |
CN (1) | CN1325501C (de) |
AT (1) | ATE433981T1 (de) |
AU (1) | AU2003224546B2 (de) |
BR (1) | BR0309345A (de) |
CA (1) | CA2482313A1 (de) |
DE (1) | DE60328010D1 (de) |
ES (1) | ES2326638T3 (de) |
HK (1) | HK1080470B (de) |
IL (1) | IL164511A0 (de) |
MX (1) | MXPA04010190A (de) |
NO (1) | NO20044995L (de) |
NZ (1) | NZ561993A (de) |
WO (1) | WO2003087104A1 (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
BR0213612A (pt) | 2001-10-02 | 2004-08-24 | Upjohn Co | Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
EA015104B1 (ru) | 2003-08-01 | 2011-06-30 | Мицубиси Танабе Фарма Корпорейшн | Новые соединения, обладающие ингибирующей активностью в отношении натрийзависимого транспортера |
US8785403B2 (en) | 2003-08-01 | 2014-07-22 | Mitsubishi Tanabe Pharma Corporation | Glucopyranoside compound |
BRPI0414633A (pt) | 2003-09-25 | 2006-11-07 | Astrazeneca Ab | composto, composição de diagnóstico, método para a doagnose de doenças ou condições, e, kit |
JP4855264B2 (ja) * | 2003-10-21 | 2012-01-18 | アストラゼネカ・アクチエボラーグ | スピロフロピリジンアリール誘導体 |
US7045530B2 (en) | 2003-12-22 | 2006-05-16 | Abbott Laboratories | Spirocyclic quinuclidinic ether derivatives |
TW200813067A (en) * | 2006-05-17 | 2008-03-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
UY30730A1 (es) | 2006-12-04 | 2008-07-03 | Mitsubishi Tanabe Pharma Corp | Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno |
SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
DK2200606T3 (en) | 2007-09-10 | 2017-12-04 | Janssen Pharmaceutica Nv | PROCEDURE FOR THE PREPARATION OF RELATIONSHIP USED AS INHIBITORS OF SGLT |
CL2008003653A1 (es) | 2008-01-17 | 2010-03-05 | Mitsubishi Tanabe Pharma Corp | Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica. |
ES2325049B2 (es) * | 2008-02-21 | 2010-03-16 | Universidade De Santiago De Compostela | Deteccion y cuantificacion de iminas ciclicas basada en la union competitiva a receptores nicotinicos de acetilcolina. |
EA201001889A1 (ru) | 2008-06-20 | 2011-08-30 | Астразенека Аб | Производные дибензотиазепина и их применение |
US9056850B2 (en) | 2008-10-17 | 2015-06-16 | Janssen Pharmaceutica N.V. | Process for the preparation of compounds useful as inhibitors of SGLT |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
EP2488515B1 (de) | 2009-10-14 | 2017-01-04 | Janssen Pharmaceutica NV | Verfahren zur herstellung von verbindungen die als sglt2 inhibitoren verwendbar sind |
US20120115799A1 (en) | 2010-05-11 | 2012-05-10 | Wenhua Wang | Pharmaceutical formulations |
ES2746850T3 (es) | 2010-05-17 | 2020-03-09 | Forum Pharmaceuticals Inc | Formulaciones farmacéuticas que comprenden formas cristalinas de clorhidrato de (R)-7-cloro-N-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida monohidratado |
EA028946B1 (ru) | 2011-04-13 | 2018-01-31 | Янссен Фармацевтика Нв | Способ получения соединений для применения в качестве ингибиторов sglt2 |
US9035044B2 (en) | 2011-05-09 | 2015-05-19 | Janssen Pharmaceutica Nv | L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
MX358512B (es) | 2012-05-08 | 2018-08-24 | Forum Pharmaceuticals Inc | Uso de (r)-7cloro-n-(quinuclidin-3-il) benzo[b] tiofeno-2-carboxamida o una sal farmacéuticamente aceptable de la misma para preparar una composición farmacéutica en el tratamiento de una disfunción cognitiva. |
GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
WO2014122474A1 (en) | 2013-02-07 | 2014-08-14 | Takeda Pharmaceutical Company Limited | Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists |
CA2914263C (en) | 2013-06-21 | 2021-05-18 | Takeda Pharmaceutical Company Limited | 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors |
GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
US20170071970A1 (en) | 2015-09-15 | 2017-03-16 | Janssen Pharmaceutica Nv | Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders |
GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
SE9900100D0 (sv) * | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
FR2788982B1 (fr) * | 1999-02-02 | 2002-08-02 | Synthelabo | Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique |
US6569865B2 (en) * | 2001-06-01 | 2003-05-27 | Astrazeneca Ab | Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine |
CN1294136C (zh) | 2001-06-01 | 2007-01-10 | 阿斯特拉曾尼卡有限公司 | 用于治疗的烟碱乙酰胆碱受体新型配体 |
-
2003
- 2003-04-15 DE DE60328010T patent/DE60328010D1/de not_active Expired - Lifetime
- 2003-04-15 US US10/511,525 patent/US7417050B2/en not_active Expired - Fee Related
- 2003-04-15 EP EP03721209A patent/EP1499616B1/de not_active Expired - Lifetime
- 2003-04-15 WO PCT/SE2003/000615 patent/WO2003087104A1/en active Application Filing
- 2003-04-15 ES ES03721209T patent/ES2326638T3/es not_active Expired - Lifetime
- 2003-04-15 AT AT03721209T patent/ATE433981T1/de not_active IP Right Cessation
- 2003-04-15 MX MXPA04010190A patent/MXPA04010190A/es active IP Right Grant
- 2003-04-15 NZ NZ561993A patent/NZ561993A/en unknown
- 2003-04-15 CA CA002482313A patent/CA2482313A1/en not_active Abandoned
- 2003-04-15 JP JP2003584060A patent/JP4523775B2/ja not_active Expired - Fee Related
- 2003-04-15 KR KR10-2004-7016545A patent/KR20040099446A/ko not_active Application Discontinuation
- 2003-04-15 CN CNB038139014A patent/CN1325501C/zh not_active Expired - Fee Related
- 2003-04-15 AU AU2003224546A patent/AU2003224546B2/en not_active Ceased
- 2003-04-15 BR BR0309345-0A patent/BR0309345A/pt not_active IP Right Cessation
-
2004
- 2004-10-11 IL IL16451104A patent/IL164511A0/xx unknown
- 2004-11-17 NO NO20044995A patent/NO20044995L/no not_active Application Discontinuation
-
2006
- 2006-01-06 HK HK06100288.5A patent/HK1080470B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL164511A0 (en) | 2005-12-18 |
CN1325501C (zh) | 2007-07-11 |
HK1080470A1 (en) | 2006-04-28 |
AU2003224546A1 (en) | 2003-10-27 |
JP4523775B2 (ja) | 2010-08-11 |
WO2003087104A1 (en) | 2003-10-23 |
AU2003224546B2 (en) | 2008-11-06 |
US20050131003A1 (en) | 2005-06-16 |
NZ561993A (en) | 2008-09-26 |
US7417050B2 (en) | 2008-08-26 |
EP1499616B1 (de) | 2009-06-17 |
KR20040099446A (ko) | 2004-11-26 |
ES2326638T3 (es) | 2009-10-16 |
CA2482313A1 (en) | 2003-10-23 |
NO20044995L (no) | 2005-01-18 |
ATE433981T1 (de) | 2009-07-15 |
EP1499616A1 (de) | 2005-01-26 |
CN1662542A (zh) | 2005-08-31 |
BR0309345A (pt) | 2005-02-15 |
MXPA04010190A (es) | 2005-02-03 |
HK1080470B (zh) | 2008-03-07 |
JP2005534624A (ja) | 2005-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60328010D1 (de) | Heterocyclische verbindungen | |
HK1079522A1 (en) | Thienyl compounds | |
DE60334536D1 (de) | Furylverbindungen | |
SE0202463D0 (sv) | Novel compounds | |
SE0401971D0 (sv) | Piperidne derivatives | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
ATE553106T1 (de) | Heteroarylpyrrolopyridinone als kinaseinhibitoren | |
IL173810A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
NO20064351L (no) | Caspaseinhibitorer og anvendelser derav | |
SE0401970D0 (sv) | Novel compounds | |
SE0301701D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0301320D0 (sv) | Positive modulators of nicotinic acetylcholine receptors | |
IL173809A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
IL173895A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
SE0203303D0 (sv) | Novel Compounds | |
NO20052994L (no) | Nye fosforamidderivater. | |
SE0301699D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0403086D0 (sv) | Compounds | |
SE0300105D0 (sv) | Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof | |
ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
MXPA04009421A (es) | Compuestos de tiazol-2-ilimina como inhibidores de la pde-7. | |
MXPA06004299A (es) | Derivados de arilespirofuropiridina. | |
MXPA05006530A (es) | Derivados de 1-n-fenilamino-1h-imidazola como inhibidores aromatasa. | |
TW200500356A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
SE0400285D0 (sv) | Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |